Nuwellis Files Definitive Proxy Statement for 2025 Annual Meeting

Ticker: NUWE · Form: DEF 14A · Filed: Apr 14, 2025 · CIK: 1506492

Nuwellis, Inc. DEF 14A Filing Summary
FieldDetail
CompanyNuwellis, Inc. (NUWE)
Form TypeDEF 14A
Filed DateApr 14, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, annual-meeting, governance

TL;DR

Nuwellis proxy filed - shareholders vote on exec pay & board soon.

AI Summary

Nuwellis, Inc. filed its definitive proxy statement on April 14, 2025, for its annual meeting on May 20, 2025. The company, formerly known as CHF Solutions, Inc. and Sunshine Heart, Inc., is seeking shareholder approval for matters related to its corporate governance and operations. The filing details executive compensation, director elections, and other proposals requiring shareholder votes.

Why It Matters

This filing provides shareholders with crucial information to make informed decisions on corporate governance matters, including executive compensation and director elections, directly impacting the company's future direction.

Risk Assessment

Risk Level: low — This is a routine proxy filing providing information to shareholders and does not inherently present new risks.

Key Players & Entities

  • Nuwellis, Inc. (company) — Registrant
  • CHF Solutions, Inc. (company) — Former company name
  • Sunshine Heart, Inc. (company) — Former company name
  • 20250414 (date) — Filing date
  • 20250520 (date) — Meeting date

FAQ

What is the purpose of this DEF 14A filing?

The purpose of this DEF 14A filing is to provide shareholders with a proxy statement for Nuwellis, Inc.'s annual meeting of shareholders, outlining proposals and information necessary for them to vote.

When is the annual meeting scheduled to take place?

The annual meeting is scheduled to take place on May 20, 2025.

What were Nuwellis, Inc.'s former names?

Nuwellis, Inc. was formerly known as CHF Solutions, Inc. and Sunshine Heart, Inc.

What is the filing date of this proxy statement?

This definitive proxy statement was filed on April 14, 2025.

What is the company's primary business classification?

Nuwellis, Inc. is classified under ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845].

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 14, 2025 regarding Nuwellis, Inc. (NUWE).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.